Literature DB >> 17161494

Antiviral therapy in HCV decompensated cirrhosis: to treat or not to treat?

Miquel Navasa, Xavier Forns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17161494     DOI： 10.1016/j.jhep.2006.11.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

1.  Hepatitis C virus RNA kinetics: drug efficacy and the rate of HCV-infected cells loss.

Authors:  Harel Dahari; Alan S Perelson
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

2.  Successful rescue therapy with only 4 weeks ribavirin monotherapy in end-stage cirrhosis due to genotype 2 chronic hepatitis C.

Authors:  Mehran Howaizi; Pierre Akue-Goeh; Françoise Maurer-Chagrin
Journal:  Dig Dis Sci       Date:  2008-06-06       Impact factor: 3.199

3.  APASL consensus statements and management algorithms for hepatitis C virus infection.

Authors:  Masao Omata; Tatsuo Kanda; Ming-Lung Yu; Osamu Yokosuka; Seng-Gee Lim; Wasim Jafri; Ryosuke Tateishi; Saeed S Hamid; Wan-Long Chuang; Anuchit Chutaputti; Lai Wei; Jose Sollano; Shiv Kumar Sarin; Jia-Horng Kao; Geoffrey W McCaughan
Journal:  Hepatol Int       Date:  2012-03-01       Impact factor: 9.029

Review 4.  APASL consensus statements and recommendation on treatment of hepatitis C.

Authors:  Masao Omata; Tatsuo Kanda; Lai Wei; Ming-Lung Yu; Wang-Long Chuang; Alaaeldin Ibrahim; Cosmas Rinaldi Adithya Lesmana; Jose Sollano; Manoj Kumar; Ankur Jindal; Barjesh Chander Sharma; Saeed S Hamid; A Kadir Dokmeci; Geofferey W McCaughan; Jafri Wasim; Darrell H G Crawford; Jia-Horng Kao; Osamu Yokosuka; George K K Lau; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2016-04-29       Impact factor: 6.047

Review 5.  Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis.

Authors:  Sofia Lachiondo-Ortega; Maria Mercado-Gómez; Marina Serrano-Maciá; Fernando Lopitz-Otsoa; Tanya B Salas-Villalobos; Marta Varela-Rey; Teresa C Delgado; María Luz Martínez-Chantar
Journal:  Cells       Date:  2019-12-04       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.